Abdul Mannan: What’s Your Approach When JAK2 Shows Up in Unusual Thrombosis?
Abdul Mannan, Consultant Haematologist at Betsi Cadwaladr University Health Board, shared on LinkedIn:
”You find JAK2V617F in a patient with splanchnic vein thrombosis.
Counts are normal. The marrow doesn’t show MPN.
Now what?
Here’s the thing: JAK2 positivity in SVT means clonal, persistent risk. It doesn’t disappear just because the blood count looks normal.
Here’s what the evidence tells us:
• JAK2+ SVT behaves as a chronic prothrombotic state, even without overt MPN on counts or marrow
• Budd-Chiari syndrome should get indefinite anticoagulation from the start (target INR 2-3 with LMWH or VKA )
• Portal or mesenteric vein thrombosis with JAK2 positivity usually needs extended or indefinite anticoagulation, tailored to bleeding risk
• Ruxolitinib (Jakavi) is NOT standard for thrombosis prevention alone – it may help if an overt MPN later declares itself, but it doesn’t replace anticoagulation
• Cytoreduction isn’t indicated when counts are truly normal
Here’s what matters for follow-up: some patients do progress to overt MPN over time
. One cohort had 30% declare MPN at a median of 41 months.
So you’re looking at periodic CBCs, iron studies if polycythemia concerns you, and keeping step with hepatology for varices and bleeding risk.
The lesson for clinic: don’t withhold anticoagulation waiting for “diagnostic” marrow features, and don’t reach for ruxolitinib to avoid anticoagulation.
Both are misses.
What’s your approach when JAK2 shows up in unusual thrombosis?”

Stay updated with Hemostasis Today.
-
Nov 21, 2026, 20:00Jeyda Star: The FAST Signs of Stroke and the Reality of Life Afterward
-
Nov 21, 2026, 19:59Daniel Lindholm: Women Showed the Largest Improvement in Stroke Risk Over Time in Heart Failure
-
Nov 21, 2026, 19:56Neil Arrowsmith: Raising Awareness of Pulmonary Embolism in Young People
-
Nov 21, 2026, 19:52Muhammad Zeeshan Jamal: Thrilled to Present Our Research on Intermediate-Risk Acute PE in Abu Dhabi
-
Nov 21, 2026, 19:50Mounisha Devireddy: Proud to Share Our Research on High-Risk PE in Pregnancy
-
Nov 21, 2026, 19:47Melissa Hollo: How Severe Anemia Increases the Odds of Acute HF During Pregnancy and Postpartum
-
Nov 21, 2026, 19:44Ashenafi Tazebew Amare: Building Sustainable Systems to Close the Anti-D Immunoglobulin Access Gap in LMICs
-
Nov 21, 2026, 19:43Sheharyar Raza: Interpreting Clotting Times Through Reptilase Time and Thrombin Time Assays
-
Nov 21, 2026, 19:42Minoo Ahmadinejad: Serving on the ISTH 2027 Scientific Theme Committee for Women’s Health